NCT03141684 2026-04-13Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part SarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting63 enrolled 2 FDA
NCT04589845 2026-04-02Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyHoffmann-La RochePhase 2 Active not recruiting920 enrolled 2 FDA